Skip to main content
SpringerLink
Log in

Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

A phase II study was conducted to determine the clinical efficacy and toxicity of 5-fluorouracil (5-FU) and low-dose cisplatin (CDDP) in patients with squamous cell carcinoma of the esophagus. Chemotherapy consisted of 5-FU at a dose of 330 mg/m2 per day, given as a 24-h infusion on days 1–7, and CDDP at a dose of 6 mg/m2 per day, given as a 2-h infusion on days 1–5. Either two or four cycles of chemotherapy were administered to 20 patients with stage III advanced esophageal carcinoma. All 20 patients were then assessed for response and toxicity. An objective response was demonstrated by 11 of the 20 patients, with one complete response (CR) and ten partial responses (PR), bringing the response rate to 55%, with a 95% confidence interval of 27% to 83%. Surgical resection of the tumor was performed in all 20 patients. One patient was found to have a grade 3 histological CR. The median survival of all the patients was 20.5 months, with a range of 4.5 to 48.0 months. Neutropenia and thrombocytopenia developed in five (25%) and two (10%) patients, respectively, and the nonhematologic toxicities were insignificant. The findings of this phase II study indicate that preoperative treatment using 5-FU and low-dose CDDP chemotherapy for patients with advanced esophageal carcinoma appears to achieve a high response rate after shortterm administration without affecting the quality of sophisticated lymph node dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Earlam R, Cunha-Meio JR (1980) Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg 67:381–390

    Article  CAS  PubMed  Google Scholar 

  2. Mansour KA, Downey RS (1989) Esophageal carcinoma: surgery without preoperative adjuvant chemotherapy. Ann Thorac Surg 48:201–205

    Article  CAS  PubMed  Google Scholar 

  3. Katlic MR, Wilkins EW Jr, Grillo HC (1990) Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 99:929–938

    CAS  PubMed  Google Scholar 

  4. Matsubara T, Ueda M, Yanagida O, Nakajima T, Nishi M (1994) How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 107:1073–1078

    CAS  PubMed  Google Scholar 

  5. Baba M, Aikoh T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219:310–316

    Article  CAS  PubMed  Google Scholar 

  6. Sharma S, Fujita H, Yamana H, Kakegawa T (1994) Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 24:330–333

    Article  Google Scholar 

  7. Nishimaki T, Suzuki T, Tanaka Y, Nakagawa S, Aizawa K, Hatakeyama K (1997) Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus. Surg Today 27:3–8

    Article  CAS  PubMed  Google Scholar 

  8. Domitsu K, Akiyama S, Ito K, Kiriyama K, Kodera Y, Kondo K, Watanabe T, Takagi H (1994) Experimental study on chemotherapy using adsorbent charcoal with CDDP administered directly into the mediastinum following esophagectomy. Surg Today 24:1068–1072

    Article  CAS  PubMed  Google Scholar 

  9. Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, Gaspar LE, Kinzie JL, Steiger Z, Vaitkevicius VK (1994) Chemoradiotherapy of esophageal carcinoma. Cancer 74:1217–1224

    Article  CAS  PubMed  Google Scholar 

  10. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE (1996) Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14:156–163

    CAS  PubMed  Google Scholar 

  11. Hou BS, Xiong QB, Li DJ (1989) Thermo-chemo-radiotherapy of esophageal cancer. Cancer 64:1777–1782

    Article  CAS  PubMed  Google Scholar 

  12. Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP (1995) A phase II trial of interferon alpha-2a, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 75:2197–2202

    Article  CAS  PubMed  Google Scholar 

  13. Imamura M, Shimada Y, Kanda Y, Fukumoto M, Yanagibashi K, Miyahara T, Tobe T (1992) Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer. Surg Today 22:409–415

    Article  CAS  PubMed  Google Scholar 

  14. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60:2156–2160

    Article  CAS  PubMed  Google Scholar 

  15. Hilgenberg AD, Carey RW, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45:357–363

    Article  CAS  PubMed  Google Scholar 

  16. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B, Mountain C (1992) Prolonged chemotherapy for localised squamous carcinom of the oesophagus. Eur J Cancer 28A:880–884

    Article  CAS  PubMed  Google Scholar 

  17. Carey RW, Hilgenberg AD, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC, Wain JC, Logan DL, Bromberg C (1993) Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 11:99–105

    Article  CAS  PubMed  Google Scholar 

  18. Coonley CJ, Bains M, Hilaris B, Chapman R, Kelsen DP (1984) Cisplatin and bleomycin in the treatment of esophageal carcinoma: a final report. Cancer 54:2351–2355

    Article  CAS  PubMed  Google Scholar 

  19. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32:167–172

    Article  CAS  PubMed  Google Scholar 

  20. Worl Health Organization (1979) WHO handbook for reporting results of cancer treatment. World Health Organization, Geneva

    Google Scholar 

  21. Akiyama S, Kodera Y, Sekiguchi H, Fujiwara M, Sakamoto J, Kondo K, Ito K, Endo T, Takagi H (1995) Preoperative intraortic ultrasonography to determine resectability in advanced oesophageal cancer. Br J Surg 82:1671–1674

    Article  CAS  PubMed  Google Scholar 

  22. Hermanek P, Sobin LH (eds) (1987) UICC International Union Against Cancer, TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  23. Japanese Society for Esophageal Disease (1992) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Kanehara, Tokyo

    Google Scholar 

  24. Rosenberg J, Lichter A, Leichman L (1989) Cancer of the esophagus. In: De Vita V, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 725–764

    Google Scholar 

  25. Kelsen D, Hilaris B, Coonley C, Chapman R, Lesser M, Dukeman M, Heelan R, Bains M (1983) Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 75:645–652

    Article  CAS  PubMed  Google Scholar 

  26. Austin JC, Postier RG, Elkins RC (1986) Treatment of esophageal cancer: the continued need for surgical resection. Am J Surg 152:592–596

    Article  CAS  PubMed  Google Scholar 

  27. MacFarlane SD, Hill LD, Jolly PC, Kozarek RA, Anderson RP (1988) Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 95:415–422

    CAS  PubMed  Google Scholar 

  28. Orringer MB, Forastiere AA, Perez-Tamato C, Urba S, Takasugi BJ, Bromberg J (1990) Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 49:348–355

    Article  CAS  PubMed  Google Scholar 

  29. Wolfe WG, Burton GV, Seigler HF, Crocker IR, Vaughn AL (1987) Early results with combined modality therapy for carcinoma of the esophagus. Ann Surg 205:563–571

    Article  CAS  PubMed  Google Scholar 

  30. Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C (1992) Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 10:1037–1043

    CAS  PubMed  Google Scholar 

  31. Urba SG, Turrisi AT (1995) Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 75:435–439

    Article  CAS  PubMed  Google Scholar 

  32. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593–1598

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery II, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, 466, Nagoya, Aichi, Japan

    Hiroyuki Sekiguchi, Seiji Akiyama, Michitaka Fujiwara, Hajime Nakamura, Ken Kondo, Yasushi Kasai, Katsuki Ito & Hiroshi Takagi

  2. Department of Surgery, Aichi Prefectural Hospital, 18 Kakemachi, Kuriyado, 444, Okazaki, Japan

    Junichi Sakamoto

Authors
  1. Hiroyuki Sekiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seiji Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michitaka Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hajime Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ken Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasushi Kasai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katsuki Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junichi Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hiroshi Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sekiguchi, H., Akiyama, S., Fujiwara, M. et al. Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus. Surg Today 29, 97–101 (1999). https://doi.org/10.1007/BF02482231

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482231

Key Words

Search

Navigation